Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
|Articles|April 24, 2023
Get alerts from AUGS
Advertisement
Never miss an issue! Get new journal Tables of Contents sent right to your email by following these steps:
- Go to
https://www.urogynecologyjournal.com/ . - Scroll down to the bottom and enter your email above “Get New Issue Alerts” or click “Get eTOC Alerts” to subscribe.
Advertisement
Related to this article
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Off-label testosterone dosing, access, and lab monitoring in the US
2
Survey: 51% of US-women report negative healthcare experiences
3
FDA holding public meeting on testosterone use in menopausal women
4
Kevin Ault, MD, on coordinating RSV prevention across maternal and pediatric care
5